Milestone Pharmaceuticals Inc
NASDAQ:MIST
Milestone Pharmaceuticals Inc
NASDAQ:MIST
Price:
1.92
USD
-2.54%
Market Cap:
$163.5m
Balance Sheet
Balance Sheet Decomposition
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Balance Sheet
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
11
|
86
|
120
|
72
|
114
|
8
|
14
|
25
|
|
| Cash Equivalents |
11
|
86
|
120
|
72
|
114
|
8
|
14
|
25
|
|
| Short-Term Investments |
16
|
0
|
0
|
70
|
0
|
57
|
52
|
44
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
4
|
2
|
|
| Other Current Assets |
0
|
1
|
2
|
5
|
4
|
6
|
3
|
2
|
|
| Total Current Assets |
28
|
88
|
123
|
149
|
119
|
72
|
73
|
74
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
3
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
3
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
28
N/A
|
88
+219%
|
123
+40%
|
150
+22%
|
120
-20%
|
75
-38%
|
75
+1%
|
75
+0%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
3
|
4
|
5
|
4
|
2
|
4
|
2
|
|
| Accrued Liabilities |
1
|
2
|
4
|
2
|
2
|
4
|
3
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
5
|
8
|
6
|
7
|
6
|
7
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
50
|
53
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
|
| Total Liabilities |
2
N/A
|
5
+181%
|
9
+89%
|
7
-19%
|
7
+4%
|
8
+13%
|
58
+622%
|
62
+7%
|
|
| Equity | |||||||||
| Common Stock |
60
|
141
|
226
|
252
|
252
|
274
|
261
|
288
|
|
| Retained Earnings |
35
|
58
|
114
|
116
|
153
|
232
|
278
|
314
|
|
| Additional Paid In Capital |
2
|
3
|
4
|
9
|
16
|
24
|
34
|
40
|
|
| Other Equity |
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
|
| Total Equity |
26
N/A
|
84
+221%
|
115
+38%
|
143
+25%
|
113
-21%
|
66
-41%
|
17
-75%
|
13
-22%
|
|
| Total Liabilities & Equity |
28
N/A
|
88
+219%
|
123
+40%
|
150
+22%
|
120
-20%
|
75
-38%
|
75
+1%
|
75
+0%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
24
|
24
|
25
|
30
|
30
|
34
|
33
|
53
|
|
Switch to:
Switch to:
See Also
Discover More
